$TBI
TrueBlue, Inc.

2023 Q2 Form 10-Q Financial Statement

#000076889923000084 Filed on April 24, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1 2022 Q4
Revenue $475.6M $465.3M $557.7M
YoY Change -16.45% -15.63% -10.33%
Cost Of Revenue $345.1M $342.2M $409.8M
YoY Change -15.98% -16.88% -9.95%
Gross Profit $130.5M $123.1M $147.8M
YoY Change -17.69% -11.96% -11.35%
Gross Profit Margin 27.44% 26.46% 26.51%
Selling, General & Admin $119.7M $122.6M $133.7M
YoY Change -1.89% 1.72% -1.6%
% of Gross Profit 91.75% 99.62% 90.45%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $6.280M $6.411M $7.258M
YoY Change -13.32% -12.02% 1.5%
% of Gross Profit 4.81% 5.21% 4.91%
Operating Expenses $126.0M $122.6M $141.0M
YoY Change 3.25% 1.72% -1.45%
Operating Profit $4.487M -$5.943M $6.858M
YoY Change -84.66% -149.57% -71.08%
Interest Expense -$980.0K $597.0K $133.0K
YoY Change -128.5% -76.27% -92.49%
% of Operating Profit -21.84% 1.94%
Other Income/Expense, Net $578.0K $1.014M
YoY Change -625.45% 100.79%
Pretax Income -$5.978M -$4.929M $6.991M
YoY Change -120.51% -139.45% -72.57%
Income Tax $1.345M -$640.0K -$54.00K
% Of Pretax Income -0.77%
Net Earnings -$7.323M -$4.289M $7.045M
YoY Change -130.5% -140.77% -65.14%
Net Earnings / Revenue -1.54% -0.92% 1.26%
Basic Earnings Per Share -$0.24 -$0.13
Diluted Earnings Per Share -$0.24 -$0.13 $213.4K
COMMON SHARES
Basic Shares Outstanding 31.02M shares 32.82M shares 32.72M shares
Diluted Shares Outstanding 30.97M shares 32.29M shares

Balance Sheet

Concept 2023 Q2 2023 Q1 2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $49.65M $47.22M $72.05M
YoY Change 53.1% 28.6% 44.41%
Cash & Equivalents $49.65M $47.22M $72.05M
Short-Term Investments
Other Short-Term Assets $22.83M $8.715M $43.88M
YoY Change 237.35% 37.09% 246.14%
Inventory
Prepaid Expenses
Receivables $267.9M $282.0M $314.3M
Other Receivables $13.41M $12.64M $0.00
Total Short-Term Assets $353.8M $371.3M $430.2M
YoY Change -12.92% -6.79% -3.34%
LONG-TERM ASSETS
Property, Plant & Equipment $153.2M $97.97M $95.82M
YoY Change 70.09% 11.65% 8.78%
Goodwill $85.05M $93.77M $93.78M
YoY Change -9.52% -1.0% -0.8%
Intangibles $13.16M $14.96M $16.21M
YoY Change -30.72% -27.62% -27.04%
Long-Term Investments
YoY Change
Other Assets $248.9M $17.15M $383.4M
YoY Change 1364.55% 3.16% 2241.28%
Total Long-Term Assets $571.0M $585.8M $589.2M
YoY Change -2.34% 0.56% 0.18%
TOTAL ASSETS
Total Short-Term Assets $353.8M $371.3M $430.2M
Total Long-Term Assets $571.0M $585.8M $589.2M
Total Assets $924.9M $957.1M $1.019B
YoY Change -6.68% -2.43% -1.34%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $48.56M $63.97M $76.64M
YoY Change -26.87% 0.67% -0.68%
Accrued Expenses $140.1M $139.5M $92.24M
YoY Change 43.24% 48.86% -17.84%
Deferred Revenue $3.825M $4.386M $3.812M
YoY Change -45.68% 508.95%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $50.01M
YoY Change -18.82%
Total Short-Term Liabilities $199.2M $214.9M $242.9M
YoY Change -14.44% -4.87% -6.06%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $26.21M
YoY Change -100.0% -100.0%
Other Long-Term Liabilities $271.6M $2.005M $280.2M
YoY Change 9324.32% -35.84% 8438.03%
Total Long-Term Liabilities $271.6M $2.005M $280.2M
YoY Change 9324.32% -71.86% 8438.03%
TOTAL LIABILITIES
Total Short-Term Liabilities $199.2M $214.9M $242.9M
Total Long-Term Liabilities $271.6M $2.005M $280.2M
Total Liabilities $470.8M $489.5M $523.1M
YoY Change -10.33% -4.65% -3.16%
SHAREHOLDERS EQUITY
Retained Earnings $473.8M $487.9M $516.3M
YoY Change -1.96% 0.98% 1.48%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $454.0M $467.6M $496.3M
YoY Change
Total Liabilities & Shareholders Equity $924.9M $957.1M $1.019B
YoY Change -6.68% -2.43% -1.34%

Cashflow Statement

Concept 2023 Q2 2023 Q1 2022 Q4
OPERATING ACTIVITIES
Net Income -$7.323M -$4.289M $7.045M
YoY Change -130.5% -140.77% -65.14%
Depreciation, Depletion And Amortization $6.280M $6.411M $7.258M
YoY Change -13.32% -12.02% 1.5%
Cash From Operating Activities $11.71M $9.151M $40.43M
YoY Change -56.07% -65.39% 103.33%
INVESTING ACTIVITIES
Capital Expenditures $7.657M $8.081M -$7.941M
YoY Change -193.23% 39.83% 27.38%
Acquisitions
YoY Change
Other Investing Activities $3.606M -$295.0K -$9.066M
YoY Change -47.3% -104.89% 2698.15%
Cash From Investing Activities -$4.051M -$8.376M -$17.01M
YoY Change 195.48% -3384.71% 159.33%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -9.471M -$26.83M 17.00K
YoY Change -66.92% -25.59% -100.1%
NET CHANGE
Cash From Operating Activities 11.71M $9.151M 40.43M
Cash From Investing Activities -4.051M -$8.376M -17.01M
Cash From Financing Activities -9.471M -$26.83M 17.00K
Net Change In Cash -1.809M -$26.04M 23.44M
YoY Change -45.9% 176.77% -821.2%
FREE CASH FLOW
Cash From Operating Activities $11.71M $9.151M $40.43M
Capital Expenditures $7.657M $8.081M -$7.941M
Free Cash Flow $4.056M $1.070M $48.37M
YoY Change -88.37% -94.82% 85.21%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0000768899
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-26
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
001-14543
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
TrueBlue, Inc.
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
WA
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
91-1287341
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
1015 A Street
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Tacoma
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
WA
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
98402
CY2023Q1 dei City Area Code
CityAreaCode
253
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
383-9101
CY2023Q1 dei Security12b Title
Security12bTitle
Common stock, no par value
CY2023Q1 dei Trading Symbol
TradingSymbol
TBI
CY2023Q1 dei Security Exchange Name
SecurityExchangeName
NYSE
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
31023360 shares
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
47223000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
72054000 usd
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
3637000 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
3212000 usd
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
282014000 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
314275000 usd
CY2023Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
29423000 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
32530000 usd
CY2023Q1 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
12639000 usd
CY2022Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
11353000 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
371299000 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
430212000 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
97972000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
95823000 usd
CY2023Q1 us-gaap Restricted Cash And Investments Noncurrent
RestrictedCashAndInvestmentsNoncurrent
212840000 usd
CY2022Q4 us-gaap Restricted Cash And Investments Noncurrent
RestrictedCashAndInvestmentsNoncurrent
213734000 usd
CY2023Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
25854000 usd
CY2022Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
25842000 usd
CY2023Q1 us-gaap Goodwill
Goodwill
93772000 usd
CY2022Q4 us-gaap Goodwill
Goodwill
93784000 usd
CY2023Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
14959000 usd
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
16205000 usd
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
50786000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
50823000 usd
CY2023Q1 tbi Workers Compensation Claim Receivables Net Of Valuation Allowance
WorkersCompensationClaimReceivablesNetOfValuationAllowance
72480000 usd
CY2022Q4 tbi Workers Compensation Claim Receivables Net Of Valuation Allowance
WorkersCompensationClaimReceivablesNetOfValuationAllowance
75185000 usd
CY2023Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
17151000 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
17800000 usd
CY2023Q1 us-gaap Assets
Assets
957113000 usd
CY2022Q4 us-gaap Assets
Assets
1019408000 usd
CY2023Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
63967000 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
76644000 usd
CY2023Q1 tbi Employee Related Liabilities Excluding Workers Compensation Liability Current
EmployeeRelatedLiabilitiesExcludingWorkersCompensationLiabilityCurrent
81095000 usd
CY2022Q4 tbi Employee Related Liabilities Excluding Workers Compensation Liability Current
EmployeeRelatedLiabilitiesExcludingWorkersCompensationLiabilityCurrent
92237000 usd
CY2023Q1 us-gaap Taxes Payable Current
TaxesPayableCurrent
165000 usd
CY2022Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
1137000 usd
CY2023Q1 us-gaap Workers Compensation Liability Current
WorkersCompensationLiabilityCurrent
46543000 usd
CY2022Q4 us-gaap Workers Compensation Liability Current
WorkersCompensationLiabilityCurrent
50005000 usd
CY2023Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
11875000 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
11963000 usd
CY2023Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
11251000 usd
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
10889000 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
214896000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
242875000 usd
CY2023Q1 us-gaap Workers Compensation Liability Noncurrent
WorkersCompensationLiabilityNoncurrent
192884000 usd
CY2022Q4 us-gaap Workers Compensation Liability Noncurrent
WorkersCompensationLiabilityNoncurrent
201005000 usd
CY2023Q1 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
29215000 usd
CY2022Q4 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
26213000 usd
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
50490000 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
50601000 usd
CY2023Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2005000 usd
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2399000 usd
CY2023Q1 us-gaap Liabilities
Liabilities
489490000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
523093000 usd
CY2023Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.131
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.131
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2023Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q1 tbi Debt Instrument Leverage Ratio Threshold
DebtInstrumentLeverageRatioThreshold
3.00
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
31507000 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
31507000 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
32730000 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
32730000 shares
CY2023Q1 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
1000 usd
CY2022Q4 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
1000 usd
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-20271000 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-20018000 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
487893000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
516332000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
467623000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
496315000 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
957113000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1019408000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
465288000 usd
CY2022Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
551515000 usd
CY2023Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
342175000 usd
CY2022Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
411670000 usd
CY2023Q1 us-gaap Gross Profit
GrossProfit
123113000 usd
CY2022Q1 us-gaap Gross Profit
GrossProfit
139845000 usd
CY2023Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
122645000 usd
CY2022Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
120568000 usd
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
6411000 usd
CY2022Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
7287000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-5943000 usd
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
11990000 usd
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1014000 usd
CY2022Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
505000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-4929000 usd
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
12495000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-640000 usd
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1976000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-4289000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
10519000 usd
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.13
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.31
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.13
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.30
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
32292000 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
33929000 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
32292000 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
34544000 shares
CY2023Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-253000 usd
CY2022Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
127000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-4542000 usd
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
10646000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-4289000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
10519000 usd
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
6411000 usd
CY2022Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
7287000 usd
CY2023Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1382000 usd
CY2022Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
989000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
2630000 usd
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
3812000 usd
CY2023Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-47000 usd
CY2022Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
1258000 usd
CY2023Q1 tbi Lease Cost Noncash Expense
LeaseCostNoncashExpense
3140000 usd
CY2022Q1 tbi Lease Cost Noncash Expense
LeaseCostNoncashExpense
3281000 usd
CY2023Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-20000 usd
CY2022Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-2608000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-31025000 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-27702000 usd
CY2023Q1 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
2512000 usd
CY2022Q1 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
1252000 usd
CY2023Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-6462000 usd
CY2022Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-4267000 usd
CY2023Q1 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-11937000 usd
CY2022Q1 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-13257000 usd
CY2023Q1 us-gaap Increase Decrease In Accrued Salaries
IncreaseDecreaseInAccruedSalaries
-11143000 usd
CY2022Q1 us-gaap Increase Decrease In Accrued Salaries
IncreaseDecreaseInAccruedSalaries
-19031000 usd
CY2023Q1 us-gaap Increase Decrease In Workers Compensation Liabilities
IncreaseDecreaseInWorkersCompensationLiabilities
-11583000 usd
CY2022Q1 us-gaap Increase Decrease In Workers Compensation Liabilities
IncreaseDecreaseInWorkersCompensationLiabilities
168000 usd
CY2023Q1 tbi Increase Decreasein Operating Leases Liabilities
IncreaseDecreaseinOperatingLeasesLiabilities
-3316000 usd
CY2022Q1 tbi Increase Decreasein Operating Leases Liabilities
IncreaseDecreaseinOperatingLeasesLiabilities
-3319000 usd
CY2023Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
2908000 usd
CY2022Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
1410000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
9151000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
26442000 usd
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
8081000 usd
CY2022Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
5779000 usd
CY2023Q1 tbi Payments To Acquire Restricted Investments Held To Maturity
PaymentsToAcquireRestrictedInvestmentsHeldToMaturity
2305000 usd
CY2022Q1 tbi Payments To Acquire Restricted Investments Held To Maturity
PaymentsToAcquireRestrictedInvestmentsHeldToMaturity
0 usd
CY2023Q1 tbi Proceeds From Maturity Of Restricted Investments Heldtomaturity
ProceedsFromMaturityOfRestrictedInvestmentsHeldtomaturity
2010000 usd
CY2022Q1 tbi Proceeds From Maturity Of Restricted Investments Heldtomaturity
ProceedsFromMaturityOfRestrictedInvestmentsHeldtomaturity
6034000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-8376000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
255000 usd
CY2023Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
24718000 usd
CY2022Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
36326000 usd
CY2023Q1 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
315000 usd
CY2022Q1 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
319000 usd
CY2023Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
2377000 usd
CY2022Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
3970000 usd
CY2023Q1 us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
0 usd
CY2022Q1 us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
4000000 usd
CY2023Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-45000 usd
CY2022Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-72000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-26825000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-36049000 usd
CY2023Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
9000 usd
CY2022Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-57000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-26041000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-9409000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
135631000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
103185000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
109590000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
93776000 usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
262000 usd
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
193000 usd
CY2023Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1912000 usd
CY2022Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1878000 usd
CY2023Q1 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
4028000 usd
CY2022Q1 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
4093000 usd
CY2023Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
3763000 usd
CY2022Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
3159000 usd
CY2023Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
3055000 usd
CY2022Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
3948000 usd
CY2023Q1 tbi Debt Instrument Leverage Ratio
DebtInstrumentLeverageRatio
0.08
CY2023Q1 us-gaap Assets Held By Insurance Regulators
AssetsHeldByInsuranceRegulators
29839000 usd
CY2022Q4 us-gaap Assets Held By Insurance Regulators
AssetsHeldByInsuranceRegulators
29567000 usd
CY2023Q1 us-gaap Assets Held In Trust Current
AssetsHeldInTrustCurrent
31408000 usd
CY2022Q4 us-gaap Assets Held In Trust Current
AssetsHeldInTrustCurrent
30857000 usd
CY2023Q1 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
123577000 usd
CY2022Q4 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
123678000 usd
CY2023Q1 us-gaap Life Insurance Corporate Or Bank Owned Amount
LifeInsuranceCorporateOrBankOwnedAmount
26896000 usd
CY2022Q4 us-gaap Life Insurance Corporate Or Bank Owned Amount
LifeInsuranceCorporateOrBankOwnedAmount
26479000 usd
CY2023Q1 us-gaap Other Restricted Assets Noncurrent
OtherRestrictedAssetsNoncurrent
1120000 usd
CY2022Q4 us-gaap Other Restricted Assets Noncurrent
OtherRestrictedAssetsNoncurrent
3153000 usd
CY2023Q1 us-gaap Restricted Cash And Investments Noncurrent
RestrictedCashAndInvestmentsNoncurrent
212840000 usd
CY2022Q4 us-gaap Restricted Cash And Investments Noncurrent
RestrictedCashAndInvestmentsNoncurrent
213734000 usd
CY2023Q1 us-gaap Held To Maturity Securities
HeldToMaturitySecurities
123577000 usd
CY2023Q1 us-gaap Held To Maturity Securities Accumulated Unrecognized Holding Gain
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain
36000 usd
CY2023Q1 us-gaap Held To Maturity Securities Accumulated Unrecognized Holding Loss
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss
3372000 usd
CY2023Q1 us-gaap Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
120241000 usd
CY2022Q4 us-gaap Held To Maturity Securities
HeldToMaturitySecurities
123678000 usd
CY2022Q4 us-gaap Held To Maturity Securities Accumulated Unrecognized Holding Gain
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain
6000 usd
CY2022Q4 us-gaap Held To Maturity Securities Accumulated Unrecognized Holding Loss
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss
4159000 usd
CY2022Q4 us-gaap Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
119525000 usd
CY2023Q1 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
417000 usd
CY2022Q1 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-2011000 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
3212000 usd
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
6687000 usd
CY2023Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1382000 usd
CY2022Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
989000 usd
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
956000 usd
CY2022Q1 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
2784000 usd
CY2023Q1 us-gaap Financing Receivable Allowance For Credit Loss Foreign Currency Translation
FinancingReceivableAllowanceForCreditLossForeignCurrencyTranslation
1000 usd
CY2022Q1 us-gaap Financing Receivable Allowance For Credit Loss Foreign Currency Translation
FinancingReceivableAllowanceForCreditLossForeignCurrencyTranslation
7000 usd
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
3637000 usd
CY2022Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
4885000 usd
CY2023Q1 tbi Prepaid Software Agreements Current
PrepaidSoftwareAgreementsCurrent
11000000 usd
CY2022Q4 tbi Prepaid Software Agreements Current
PrepaidSoftwareAgreementsCurrent
9994000 usd
CY2023Q1 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
9708000 usd
CY2022Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
9455000 usd
CY2023Q1 us-gaap Other Assets Current
OtherAssetsCurrent
8715000 usd
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
13081000 usd
CY2023Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
29423000 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
32530000 usd
CY2023Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
4386000 usd
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
3812000 usd
CY2023Q1 us-gaap Other Sundry Liabilities Current
OtherSundryLiabilitiesCurrent
6865000 usd
CY2022Q4 us-gaap Other Sundry Liabilities Current
OtherSundryLiabilitiesCurrent
7077000 usd
CY2023Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
11251000 usd
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
10889000 usd
CY2023Q1 tbi Weighted Average Period Claim Payments Below Deductible Limit
WeightedAveragePeriodClaimPaymentsBelowDeductibleLimit
P6Y
CY2023Q1 us-gaap Workers Compensation Liability Current And Noncurrent
WorkersCompensationLiabilityCurrentAndNoncurrent
259087000 usd
CY2022Q4 us-gaap Workers Compensation Liability Current And Noncurrent
WorkersCompensationLiabilityCurrentAndNoncurrent
270468000 usd
CY2023Q1 us-gaap Workers Compensation Discount Amount
WorkersCompensationDiscountAmount
19660000 usd
CY2022Q4 us-gaap Workers Compensation Discount Amount
WorkersCompensationDiscountAmount
19458000 usd
CY2023Q1 tbi Workers Compensation Liability Netof Discount
WorkersCompensationLiabilityNetofDiscount
239427000 usd
CY2022Q4 tbi Workers Compensation Liability Netof Discount
WorkersCompensationLiabilityNetofDiscount
251010000 usd
CY2023Q1 us-gaap Workers Compensation Liability Current
WorkersCompensationLiabilityCurrent
46543000 usd
CY2022Q4 us-gaap Workers Compensation Liability Current
WorkersCompensationLiabilityCurrent
50005000 usd
CY2023Q1 us-gaap Workers Compensation Liability Noncurrent
WorkersCompensationLiabilityNoncurrent
192884000 usd
CY2022Q4 us-gaap Workers Compensation Liability Noncurrent
WorkersCompensationLiabilityNoncurrent
201005000 usd
CY2023Q1 us-gaap Payments For Losses And Loss Adjustment Expense
PaymentsForLossesAndLossAdjustmentExpense
11900000 usd
CY2022Q1 us-gaap Payments For Losses And Loss Adjustment Expense
PaymentsForLossesAndLossAdjustmentExpense
9700000 usd
CY2023Q1 tbi Weighted Average Period Claim Payments And Receivables Above Deductible Limit
WeightedAveragePeriodClaimPaymentsAndReceivablesAboveDeductibleLimit
P17Y
CY2023Q1 tbi Discountedworkerscompensationreserveforexcessclaims
Discountedworkerscompensationreserveforexcessclaims
73900000 usd
CY2022Q4 tbi Discountedworkerscompensationreserveforexcessclaims
Discountedworkerscompensationreserveforexcessclaims
76700000 usd
CY2023Q1 tbi Workers Compensation Claim Receivables
WorkersCompensationClaimReceivables
72500000 usd
CY2022Q4 tbi Workers Compensation Claim Receivables
WorkersCompensationClaimReceivables
75200000 usd
CY2023Q1 tbi Workers Compensation Expense
WorkersCompensationExpense
4800000 usd
CY2022Q1 tbi Workers Compensation Expense
WorkersCompensationExpense
11300000 usd
CY2023Q1 tbi Debt Instrument Fixed Charge Coverage Ratio Threshold
DebtInstrumentFixedChargeCoverageRatioThreshold
1.25
CY2023Q1 tbi Debt Instrument Fixed Charge Coverage Ratio
DebtInstrumentFixedChargeCoverageRatio
62.63
CY2023Q1 tbi Collateral Commitments Cash Collateral Held By Insurance Carriers
CollateralCommitmentsCashCollateralHeldByInsuranceCarriers
23985000 usd
CY2022Q4 tbi Collateral Commitments Cash Collateral Held By Insurance Carriers
CollateralCommitmentsCashCollateralHeldByInsuranceCarriers
23716000 usd
CY2023Q1 us-gaap Assets Held In Trust Current
AssetsHeldInTrustCurrent
31408000 usd
CY2022Q4 us-gaap Assets Held In Trust Current
AssetsHeldInTrustCurrent
30857000 usd
CY2023Q1 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
123577000 usd
CY2022Q4 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
123678000 usd
CY2023Q1 tbi Collateral Commitments Lettersof Credit
CollateralCommitmentsLettersofCredit
6077000 usd
CY2022Q4 tbi Collateral Commitments Lettersof Credit
CollateralCommitmentsLettersofCredit
6077000 usd
CY2023Q1 tbi Collateral Commitments Surety Bonds
CollateralCommitmentsSuretyBonds
20725000 usd
CY2022Q4 tbi Collateral Commitments Surety Bonds
CollateralCommitmentsSuretyBonds
20806000 usd
CY2023Q1 tbi Collateral Commitments Total Collateral Commitments
CollateralCommitmentsTotalCollateralCommitments
205772000 usd
CY2022Q4 tbi Collateral Commitments Total Collateral Commitments
CollateralCommitmentsTotalCollateralCommitments
205134000 usd
CY2023Q1 tbi Collateral Commitments Surety Bond Annual Fee Limit Percentage Of Bond Amount
CollateralCommitmentsSuretyBondAnnualFeeLimitPercentageOfBondAmount
0.020
CY2023Q1 tbi Collateral Commitments Surety Bonds Required Cancellation Notice
CollateralCommitmentsSuretyBondsRequiredCancellationNotice
P60D
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
467623000 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
467551000 usd
CY2023Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.130
CY2023Q1 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-4289000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
10519000 usd
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
32292000 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
33929000 shares
CY2023Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
CY2022Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
615000 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
32292000 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
34544000 shares
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.13
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.31
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.13
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.30
CY2023Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1072000 shares
CY2022Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
348000 shares
CY2023Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
465288000 usd
CY2022Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
551515000 usd
CY2023Q1 tbi Operating Profit Loss From Segments
OperatingProfitLossFromSegments
9593000 usd
CY2022Q1 tbi Operating Profit Loss From Segments
OperatingProfitLossFromSegments
30170000 usd
CY2023Q1 tbi Work Opportunity Tax Credit Processing Fees
WorkOpportunityTaxCreditProcessingFees
120000 usd
CY2022Q1 tbi Work Opportunity Tax Credit Processing Fees
WorkOpportunityTaxCreditProcessingFees
162000 usd
CY2023Q1 us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
868000 usd
CY2022Q1 us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
747000 usd
CY2023Q1 us-gaap Restructuring Charges
RestructuringCharges
32000 usd
CY2022Q1 us-gaap Restructuring Charges
RestructuringCharges
2550000 usd
CY2023Q1 us-gaap Other Nonrecurring Income Expense
OtherNonrecurringIncomeExpense
1397000 usd
CY2022Q1 us-gaap Other Nonrecurring Income Expense
OtherNonrecurringIncomeExpense
136000 usd
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
6411000 usd
CY2022Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
7287000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-5943000 usd
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
11990000 usd
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1014000 usd
CY2022Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
505000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-4929000 usd
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
12495000 usd

Files In Submission

Name View Source Status
0000768899-23-000084-index-headers.html Edgar Link pending
0000768899-23-000084-index.html Edgar Link pending
0000768899-23-000084.txt Edgar Link pending
0000768899-23-000084-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tbi-20230326.htm Edgar Link pending
tbi-20230326.xsd Edgar Link pending
tbi-20230326_g1.jpg Edgar Link pending
tbi10q032623ex101.htm Edgar Link pending
tbi10q032623ex311.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
tbi-20230326_def.xml Edgar Link unprocessable
tbi-20230326_lab.xml Edgar Link unprocessable
tbi-20230326_pre.xml Edgar Link unprocessable
tbi-20230326_htm.xml Edgar Link completed
tbi10q032623ex312.htm Edgar Link pending
tbi10q032623ex321.htm Edgar Link pending
tbi-20230326_cal.xml Edgar Link unprocessable